Literature DB >> 2401273

Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene.

A R Dahl1, W E Bechtold, J A Bond, R F Henderson, J L Mauderly, B A Muggenburg, J D Sun, L S Birnbaum.   

Abstract

Species differences in sensitivity to carcinogenic effects from inhaled 1,3-butadiene might stem, at least in part, from differences in uptake, metabolism, and distribution of 1,3-butadiene. To examine this possibility, rats, mice, and monkeys were exposed to stepped concentrations of 14C-labeled 1,3-butadiene and the chemically related compound, isoprene. Respiratory data were collected during exposure and were used to determine fractional uptake. Rates and routes of excretion of retained radioactivity were also determined and blood levels of potentially toxic metabolites were measured. In some cases, the concentrations of hemoglobin adducts were determined. For rodents, the tissue distribution of metabolites was examined. Some results from these continuing studies to date are: a) mice achieve higher blood concentrations of reactive metabolites than do rats; b) blood levels of toxic metabolites are lower in monkeys than in rodents; c) uptake and retention of 1,3-butadiene is nonlinear in the range where long-term toxicity studies have been conducted; d) the efficiency of production of reactive metabolites decreases with increased inhaled concentrations of 1,3-butadiene; e) repeated exposure to 1,3-butadiene does not induce the metabolism of 1,3-butadiene in rodents; f) hemoglobin adducts of 1,3-butadiene are potential dosimeters of exposure; and g) rats inhaling isoprene produce reactive metabolites analogous to those produced during inhalation of 1,3-butadiene. The available data indicate that major differences in the biological fate of inhaled 1,3-butadiene occur among species, and these differences, at least in part, account for those in species sensitivity to the toxicity of inhaled 1,3-butadiene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401273      PMCID: PMC1567764          DOI: 10.1289/ehp.908665

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  Trace composition of human respiratory gas.

Authors:  J P Conkle; B J Camp; B E Welch
Journal:  Arch Environ Health       Date:  1975-06

2.  Cytogenetic and other biological effects of 239PuO2 inhaled by the rhesus monkey.

Authors:  R J LaBauve; A L Brooks; J L Mauderly; F F Hahn; H C Redman; C Macken; D O Slauson; J A Mewhinney; R O McClellan
Journal:  Radiat Res       Date:  1980-05       Impact factor: 2.841

3.  A method for the continuous measurement of respiration and vapor uptake in rats.

Authors:  A R Dahl; T P Gugliotta; R L Hanson; J L Mauderly; S J Rothenberg
Journal:  Am Ind Hyg Assoc J       Date:  1987-06

4.  The fate of isoprene inhaled by rats: comparison to butadiene.

Authors:  A R Dahl; L S Birnbaum; J A Bond; P G Gervasi; R F Henderson
Journal:  Toxicol Appl Pharmacol       Date:  1987-06-30       Impact factor: 4.219

5.  Species differences in the distribution of inhaled butadiene in tissues.

Authors:  J A Bond; A R Dahl; R F Henderson; L S Birnbaum
Journal:  Am Ind Hyg Assoc J       Date:  1987-10

6.  Pharmacokinetics of isoprene in mice and rats.

Authors:  H Peter; H J Wiegand; H M Bolt; H Greim; G Walter; M Berg; J G Filser
Journal:  Toxicol Lett       Date:  1987-03       Impact factor: 4.372

7.  Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds.

Authors:  P G Gervasi; L Citti; M Del Monte; V Longo; D Benetti
Journal:  Mutat Res       Date:  1985 Apr-May       Impact factor: 2.433

8.  Species differences in the disposition of inhaled butadiene.

Authors:  J A Bond; A R Dahl; R F Henderson; J S Dutcher; J L Mauderly; L S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  1986-07       Impact factor: 4.219

9.  Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure.

Authors:  J E Huff; R L Melnick; H A Solleveld; J K Haseman; M Powers; R A Miller
Journal:  Science       Date:  1985-02-01       Impact factor: 47.728

10.  Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice.

Authors:  R J Laib; J G Filser; R Kreiling; R R Vangala; H M Bolt
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

View more
  6 in total

1.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation.

Authors:  G Johanson; J G Filser
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

2.  Human physiologic factors in respiratory uptake of 1,3-butadiene.

Authors:  Y S Lin; T J Smith; K T Kelsey; D Wypij
Journal:  Environ Health Perspect       Date:  2001-09       Impact factor: 9.031

3.  Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction.

Authors:  Lya G Soeteman-Hernández; Peter M J Bos; Reinskje Talhout
Journal:  Toxicol Sci       Date:  2013-09-06       Impact factor: 4.849

4.  hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant.

Authors:  J B Ward; M M Ammenheuser; W E Bechtold; E B Whorton; M S Legator
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

Review 5.  A brief survey of butadiene health effects: a role for metabolic differences.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

6.  Physiologically based toxicokinetic modeling of 1,3-butadiene lung metabolism in mice becomes more important at low doses.

Authors:  C T Evelo; J G Oostendorp; W F ten Berge; P J Borm
Journal:  Environ Health Perspect       Date:  1993-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.